From Checkmate News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Three cycles of neoadjuvant nivolumab plus chemotherapy improved long-term clinical outcomes in patients with resectable stage IB-IIIA NSCLC.

Patrickm fordeNivolumab opdivoBristol myers squibbJohns hopkins kimmel cancer centerDrug administrationMedscape professional networkNew england journalThoracic oncologyFrom checkmateMedscape professionalLung cancerUng carcinomaAncer lungNon small cell lung cancerMedical literature